Webcast Recording: Tissue-Based CDx Development and Image Analysis in a Regulated Space

Recently Flagship hosted a webcast on Tissue-Based CDx Development and Image Analysis in a Regulated space. Our discussion stems from the fact that the United States Food and Drug Administration (FDA) requires comprehensive analytical validation and clinical evaluation of new in vitro diagnostic (IVD) tests as companion diagnostics (CDx) to demonstrate that an IVD is safe and effective. We covered that a CDx can be an IVD or imaging tool.

As precision-based medicine expands across therapeutic areas like oncology, accompanying diagnostics are greatly optimized by digital image analysis (IA) tools that support pathologist decisions. To maximize budget, time, and other resources, it is important that CDx development is understood early in the context of existing regulations and the specifics of a drug development program.

Moderated by Meredith James, Chief Operating Officer, Flagship Biosciences, our multidisciplinary panel of experts provided insights into tissue-based (biomarker) IVDs/CDx development and how the integration of IA tools can advance and accelerate CDx development from drug discovery to clinical trials and drug approval.

Our expert panelists included:

  • David Sidransky, M.D., Professor of Oncology, Otolaryngology, Urology, Pathology, and Genetics, The Johns Hopkins University
  • Mike Kagey, Ph.D., Senior Director of Translational Medicine, Leap Therapeutics 
  • Suzana Corritori, M.D., M.S., President, Corritori Consulting
  • Roberto Gianani, M.D., Chief Medical Officer, Flagship Biosciences

You’ll even get to hear a bit of a case study from Mike at Leap Therapeutics. 

Or if you’re ready to schedule a consultation with Flagship to discuss your drug development or regulatory challenges, contact us!

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

Spatial Biology East Coast US 2024

Meet with us at booth #25. As a Gold Sponsor for the third annual Spatial Biology East Coast Congress in Boston, we hope you’ll join our experts and over 350 other industry leaders to discuss the transforming field of spatial biology. Examine how spatial biology can...

2024 Annual Meeting

Meet with us at booth #37085. We help you analyze more data in more depth, so you can produce more effective therapies. Attending the 2024 ASCO® Annual Meeting? Schedule a meeting with our team to discuss our: AI-powered digital pathology solutions Biomarker...

2024 ASGCT Annual Meeting

Are you attending the 2024 ASGCT Annual Meeting? With field-leading keynotes, 200+ scientific sessions, over 7,000 researchers in attendance, and an expanded exhibit hall, the 27th American Society of Gene and Cell Therapy Annual Meeting is the nexus for gene and cell...

AACR Annual Meeting 2024

Meet with us at the AACR Annual Meeting 2024 to learn about our spatial biology solutions. Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the...

Spatial Biology for Immuno-Oncology Summit 2024

Meet with us at the Spatial Biology for Immuno-Oncology Summit.The Spatial Biology for Immuno-Oncology Summit is back for its second year, and Flagship Biosciences is a Program Partner for the event. Join us January 23-25 in San Diego where key industry leaders will...